SpineX Receives FDA Breakthrough Device Designation for SCiP
02. Mai 2022 12:15 ET
|
SpineX
SpineX’s Proprietary non-surgical Device SCiP Offers New Hope for children with Cerebral Palsy LOS ANGELES, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early stage medtech company...
SpineX Announces Successful First in Human Study Results of SCONE therapy to treat Urge Urinary Incontinence
23. März 2022 13:00 ET
|
SpineX
SpineX’s Proprietary non-surgical SCONE™ Device Offers New Hope millions of individuals suffering from overactive bladder LOS ANGELES, March 23, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early...
Groundbreaking Study Establishes Non-surgical Treatment Modality for Bowel Function in Individuals Living With Spinal Cord Injury
17. Februar 2022 10:00 ET
|
SpineX
LOS ANGELES, Feb. 17, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., today announced the publication of new data in the esteemed neuroscience journal, Frontiers in Neuroscience. This new publication...
Groundbreaking Study Establishes Non-Surgical Treatment Modality to Improve Function in Children With Cerebral Palsy
13. Juli 2021 12:00 ET
|
SpineX
LOS ANGELES, July 13, 2021 (GLOBE NEWSWIRE) -- SpineX, Inc., today announced the publication of new data in the esteemed medical journal, Neurotherapeutics which supports the implementation of their...
SpineX Names Scientific Advisory Board to Guide Development of Non-Invasive Medical Devices for Neuromodulation of the Spine
26. Februar 2019 08:15 ET
|
SpineX
LOS ANGELES, Feb. 26, 2019 (GLOBE NEWSWIRE) -- SpineX, a developer of non-invasive medical devices to address a broad range of medical conditions through the neuromodulation of the spinal cord to...
SpineX Launches to Develop Non-Invasive Neuromodulation Devices to Address a Range of Medical Conditions
03. Januar 2019 05:00 ET
|
SpineX
LOS ANGELES, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Dr. V. Reggie Edgerton, the leading researcher into the neural control of movement and neuromuscular plasticity, today announced the launch of SpineX,...